Alar Pharmaceuticals Inc.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

32

Website

alarpharm.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2016

Alar Pharmaceuticals Inc., a drug development company focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder.

Its portfolio also includes ALA-4000 to treat Parkinson's disease, ALA-3000 for treating treatment-resistant depression, and ALA-5000 to treat schizophrenia. Founded in 2016, Alar Pharmaceuticals is based in Taichung, Taiwan.

Key Stats

52-Week Range

NT$97.50NT$317.00

Beta0.08

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-1.69

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.